HK$5.01
0.20%
Hong Kong, Oct 23, 04:08 pm HKT. Closed.
ISIN
KYG4987A1094
Symbol
1167

Jacobio Pharmaceuticals Grou Stock price

HK$5.01
-1.18 19.01% 1M
-2.36 32.00% 6M
-1.37 21.43% YTD
-2.18 30.29% 1Y
+1.47 41.38% 3Y
-13.64 73.15% 5Y
-9.42 65.29% 10Y
-9.42 65.29% 20Y
Hong Kong, Closing price Fri, Oct 23 2026
-0.01 0.20%
ISIN
KYG4987A1094
Symbol
1167
Industry

AI Insights on Jacobio Pharmaceuticals Grou Insights AI Insights on Jacobio Pharmaceuticals Grou

How does the company make money?
Who are the company’s main competitors?

Is Jacobio Pharmaceuticals Grou a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,102 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$3.9b
Enterprise Value
HK$2.2b
Net debt
positive
Cash
HK$2.0b
Shares outstanding
782.2m
Valuation
P/E
6.5
P/S | estimate
4.5 | 4.3
EV/Sales | estimate
2.5 | 2.4
EV/FCF | ex SBC
- | -
P/B
2.5
Financial Health
Equity Ratio
59.1%
Return on Equity
-18.9%
ROCE
29.5%
ROIC
-5,654.3%
Debt/Equity
0.1
Financials
Revenue | estimate
HK$868.1m | HK$918.5m
EBITDA
-
EBIT
HK$574.5m
Net Income
HK$603.6m
Free Cash Flow | ex SBC
- | -
Growth
Revenue | estimate
266.9% | 1,360.3%
EBITDA
-
EBIT
766.4%
Net Income
1,225.2%
Free Cash Flow
-
Margin
Gross
97.5%
EBITDA
-
EBIT
66.2%
Net
69.5%
Free Cash Flow | ex SBC
- | -
More
EPS
HK$0.8
FCF per Share
-
Short interest
-
Employees
196
Rev per Employee
HK$320.0k

Jacobio Pharmaceuticals Grou Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Jacobio Pharmaceuticals Grou forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Jacobio Pharmaceuticals Grou forecast:

Buy
75%
Hold
25%

Financial data from Jacobio Pharmaceuticals Grou

Jun '26
+/-
%
868 868
267% 267%
100%
- Direct Costs 22 22
-
3%
846 846
258% 258%
97%
- Selling and Administrative Expenses 38 38
15% 15%
4%
- Research and Development Expense 209 209
25% 25%
24%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 575 575
766% 766%
66%
Net Profit 604 604
1,225% 1,225%
70%

In millions HKD.

Don't miss a Thing! We will send you all news about Jacobio Pharmaceuticals Grou directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Jacobio Pharmaceuticals Group Co., Ltd. is an investment holding company, which engages in the research and development of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 196 full-time employees. The company went IPO on 2020-12-21. The firm is primarily responsible for the independent discovery and development of innovative tumor therapies. The firm's main drug development projects include JAB-21822 and JAB-3312 clinical stage allosteric SHP2 inhibitors. The firm mainly operates its businesses in China market.

Head office Cayman Islands
CEO Dr. Wang
Employees 196
Website www.jacobiopharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today